帕金森病大鼠肠功能障碍及血清脑肠肽与脑内酪氨酸羟化酶相关性研究
[Abstract]:Objective: to observe the behavioral changes and gastrointestinal dysfunction in PD rats induced by rotenone, and to determine the cholecystokinin (CCK), in serum. The correlation between the content of new fat factor (Nesfatin-1) and the average optical density of tyrosine hydroxylase (TH) in nigra striatum to study whether brain intestinal peptide can be used as an early diagnostic index of PD. The changes of average optical density of TH at different time and different sites were measured to explore the early pathogenesis of PD. Methods: 84 rats were randomly divided into experimental group (n = 42) and solvent group (n = 42). The experimental group was injected with rotenone sunflower oil emulsion (2mg/ml) subcutaneously, and the solvent group was injected with the same volume sunflower oil emulsion for 0 weeks. The rats' body weight, step test and suspension test, the percentage of fecal water content and the percentage of gastric contents in body weight were measured by immunohistochemical method after 30 minutes of injection for 2 weeks, 4 weeks and 6 weeks. The mean optical density of tyrosine hydroxylase (TH) in thoracic spinal cord and nigra striatum was measured by ELISA. The contents of CCK and Nesfatin-1 in brain intestine were determined by ELISA method. The relationship between serum CCK,Nesfatin-1 and TH in brain was analyzed by Pearson assay. Results: the behavior test showed that the weight of the experimental group was significantly lower than that of the solvent group (P0.05). The scores of suspension test in the experimental group were significantly decreased (P0.05), especially in the 4th week of the experiment group, but the degree of the decrease was slower after 4 weeks. The number of stride in the experimental group was significantly decreased (P0.05), while the weight of the rats in the solvent group was significantly decreased (P0.05), and the weight of the rats in the solvent group was significantly lower than that in the control group. There was no significant change in suspension test and step test (P0.05). The percentage of fecal water content and gastric contents in body weight was significantly decreased (P0.05) and the percentage of gastric contents in body weight was significantly increased (P0.05) in the experimental group from the second week. Compared with the solvent group, the content of CCK and Nesfatin-1 in the serum of the experimental group increased significantly from the second week (P0.05), and the content of Nesfatin-1 decreased gradually after 6 weeks. No significant change was found in the solvent group (P0.05). The results of immunohistochemistry showed that the average optical density of TH in rectum, thoracic pulp and striatum of nigra decreased significantly in the experimental group (P0.05), and the rectum showed a more obvious downward trend from the second week. However, the mean optical density of TH in the intestinal tract, thoracic spinal cord and substantia nigra was not significantly changed in the solvent group (P0.05). From the dynamic changes of serum CCK content and TH optical density in the brain of experimental rats, it was found that there was a negative correlation between the two changes with time (P0.05). There was no significant correlation between the content of Nesfatin-1 in serum and the average optical density of TH in nigra striatum in the experimental group (P0.05). Conclusion: the level of CCK in serum of Parkinson's disease rats was significantly increased at the early stage, which was negatively correlated with dopaminergic neurons in the brain, suggesting that serum CCK may be used as a predictor of early PD.
【学位授予单位】:南华大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R742.5
【参考文献】
相关期刊论文 前10条
1 石丽敏;姜宏;谢俊霞;;帕金森病和阿尔茨海默病中Ghrelin的神经保护作用研究进展[J];生理科学进展;2014年02期
2 Wei Huang;Shu-Man Jiang;Lin Jia;Le-Qing You;Yao-Xing Huang;Yan-Mei Gong;Gui-Qin Wang;;Effect of amitriptyline on gastrointestinal function and brain-gut peptides: A double-blind trial[J];World Journal of Gastroenterology;2013年26期
3 朱镛连;;神经递质与疾病和药物康复[J];中国康复理论与实践;2011年02期
4 李林;张博爱;;帕金森病的消化系统功能紊乱[J];国际神经病学神经外科学杂志;2010年06期
5 赵喜林,顾振纶,秦正红;长期低剂量皮下注射鱼藤酮制作大鼠帕金森病模型[J];中国药理学通报;2005年10期
6 马晓凯,范凯;P物质与帕金森病[J];大连医科大学学报;2005年02期
7 李云鹏,董兆君,王仕丽,蔡颖,李奇慧,乐卫东;重复注射鱼藤酮对中枢多巴胺神经元的毒性作用[J];第三军医大学学报;2003年13期
8 陈大庆,倪宏;缩胆囊素生物学作用的多样性[J];国外医学(儿科学分册);2002年03期
9 ;乙醇心血管保护作用的潜在机制(英文)[J];Acta Pharmacologica Sinica;2000年05期
10 谢俊霞,孙朝晖,蒋正尧,唐明;CCK-8及损毁MFB对腹侧被盖区和伏核多巴胺、CCK-8含量的影响[J];中国神经科学杂志;2000年01期
相关会议论文 前1条
1 栾守婧;付文玉;庄文欣;马璐璐;王晓晓;;帕金森病大鼠中缝背核5-HT、NPY、SP蛋白及mRNA的表达变化[A];中国解剖学会2013年年会论文文摘汇编[C];2013年
相关博士学位论文 前2条
1 陈路;培补肝肾复方治疗帕金森病及其肠功能障碍的疗效研究[D];北京中医药大学;2013年
2 沈晓丽;Nesfatin-1对多巴胺能神经元的保护作用及机制探讨[D];青岛大学;2014年
相关硕士学位论文 前1条
1 何珊;帕金森病模型大鼠脑内TH表达变化的实验研究[D];扬州大学;2014年
,本文编号:2390934
本文链接:https://www.wllwen.com/yixuelunwen/shenjingyixue/2390934.html